Tenpoint Therapeutics GmbH remote jobs and company guide

Tenpoint Therapeutics™ is a global, commercial-ready biotechnology company dedicated to rejuvenating vision for the aging eye. Founded with the mission to address the most pressing challenges in major ophthalmic conditions with the highest unmet need and greatest global market potential, the company is pioneering novel ophthalmic and regenerative therapies designed to improve patient lives.

The company's groundbreaking treatments aim to restore and rejuvenate vision, redefining what's possible for the aging eye. Tenpoint Therapeutics is actively working with eye care providers to enhance clinical and patient care for age-related ophthalmologic diseases. With a pipeline targeting presbyopia, cataracts, and geographic atrophy, the company has emerged as a leader in the ophthalmic space. In January 2026, the U.S. FDA approved YUVEZZI™ as the first and only dual-agent, once-daily presbyopia-correcting eye drop, marking a historic milestone in presbyopia treatment. The company secured $235 million through Series B financing to accelerate commercialization of this breakthrough therapy.